Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Country

Australia (1)
Austria (4)
Belgium (4)
Brazil (1)
Cambodia (1)
China (1)
Colombia (1)
Croatia (1)
Cuba (1)
Denmark (4)
Ecuador (1)
Finland (3)
France (11)
French Polynesia (1)
Germany (10)
Greece (1)
Iceland (1)
India (1)
Israel (1)
Italy (5)
Luxembourg (1)
Mexico (1)
Netherlands (12)
New Caledonia (1)
Norway (1)
Pakistan (1)
Poland (1)
Portugal (1)
Romania (1)
Senegal (1)
Spain (3)
Sri Lanka (1)
Sweden (2)
Switzerland (5)
United Kingdom (12)
United States (2)

Advanced search

Search projects and results

Results 1 - 10 of 13
Order by: Results/page:
12 > 
Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome
ID: 755225
Start date: 2018-01-01, End date: 2022-12-31
Crigler-Najjar syndrome (CN) is a rare recessive disorder caused by mutations in the uridine diphosphate glucuronosyltransferase 1A1(UGT1A1) gene. CN is a life-threatening disease with no cure which constitutes a severe burden for the patients, their families, and the society...
Programme: H2020-EU.3.1.3.
Record Number: 212689
Last updated on: 2018-01-23
Understanding the dynamic determinants of glucose homeostasis and social capability to promote Healthy and active aging
ID: 633595
Start date: 2015-04-01, End date: 2019-03-31
The Gluco-Psychosocial Axis (GPA) concerns the interplay of factors determining glucose metabolism and insulin sensitivity and the neuroendocrine response resulting from exposure to psychosocial stress. A sub-optimal GPA influences the development of type 2 diabetes and...
Programme: H2020-EU.3.1.1.
Record Number: 193247
Last updated on: 2017-09-11
A global alliance for Zika virus control and prevention
ID: 734548
Start date: 2016-10-01, End date: 2019-09-30
"ZIKAlliance is a multidisciplinary project with a global ""One Health"" approach, built: on a multi-centric network of clinical cohorts in the Caribbean, Central & South America; research sites in countries where the virus has been or is currently circulating (Africa, Asia...
Programme: H2020-EU.3.1.3.
Record Number: 207455
Last updated on: 2017-08-23
Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication
ID: 633545
Start date: 2015-05-01, End date: 2017-12-31
Cystic fibrosis (CF) is a progressive life-shortening disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene leading to a dysfunctional CFTR protein. The disease affects over 70,000 patients worldwide and while many mutations are...
Programme: H2020-EU.3.1.
Record Number: 193242
Last updated on: 2017-08-22
A Systems medicine approach to chronic inflammatory disease
ID: 733100
Start date: 2017-01-01, End date: 2022-03-31
"The SYSCID consortium aims to develop a systems medicine approach for disease prediction in CID. We will focus on three major CID indications with distinct characteristics, yet a large overlap of their molecular risk map: inflammatory bowel disease, systemic lupus...
Programme: H2020-EU.3.1.1.
Record Number: 207217
Last updated on: 2017-08-17
Common mechanisms and pathways in Stroke and Alzheimer's disease.
ID: 667375
Start date: 2015-12-01, End date: 2020-11-30
Common mechanisms and pathways in Stroke and Alzheimer's disease.It has long been recognized that stroke and (Alzheimer’s Disease) AD often co-occur and have an overlapping pathogenesis. As such, these two diseases are not considered fellow travelers, but rather partners in...
Programme: H2020-EU.3.1.
Record Number: 199731
Last updated on: 2017-08-17
Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseases
ID: 667837
Start date: 2016-01-01, End date: 2019-12-31
Up to 70% of cardiovascular events are not prevented by current therapeutic regimens. In search for additional, innovative strategies, immune cells have been recognized as key players contributing to atherosclerotic plaque progression and destabilization. Particularly the role...
Programme: H2020-EU.3.1.
Record Number: 199740
Last updated on: 2017-08-05
GlucoCEST Imaging of Neoplastic Tumours
ID: 667510
Start date: 2016-01-01, End date: 2019-12-31
Cancer is one of the most devastating diseases the world is currently facing, accounting for 7.6 million deaths in 2008 (WHO). Cancer is usually detected through advanced medical imaging. Early detection is very important as it increases the chances of survival and the...
Programme: H2020-EU.3.1.
Record Number: 199734
Last updated on: 2017-07-14
Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen
ID: 115854
Start date: 2014-12-01, End date: 2019-11-30
The overall aim of the EBOVAC programme is to assess the safety and efficacy/effectiveness, if feasible, of a novel prime-boost prophylactic vaccine regimen against Ebola Virus Disease (EVD), which has been 100% effective in preclinical studies. This will be done via phase I...
Programme: H2020-EU.3.1.7.13.
Record Number: 209452
Last updated on: 2017-03-27
RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities
ID: 668036
Start date: 2015-11-01, End date: 2020-04-30
RELENT is multidisciplinary group of scientists and clinical investigators whose goal is to develop individualized treatment for chronic autoimmune diseases, such as rheumatoid arthritis and vasculitis, that cause considerable mortality and morbidity, both from uncontrolled...
Programme: H2020-EU.3.1.
Record Number: 199747
Last updated on: 2017-03-20
12 > 
List retrieved on: 2018-04-26
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top